CLINICAL ROLE -
FDA Grants Accelerated Approval to Keytruda for Merkel Cell Carcinoma
Officials with the FDA have granted accelerated approval to pembrolizumab (Keytruda, Merck) for adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma (MCC).
Read More
12 Tips for Staying Healthy During the Holidays
With the holiday season in full swing, managing your health might be the last thing on your mind.
Trending News Today: Federal Judge Considers Monitoring CVS to Prevent Aetna Integration
Top news of the day across the health care landscape.
Patient Satisfaction in the Specialty Pharmacy Space
As is the case with any service-driven industry, the need to continually assess end-user satisfaction is paramount.
First-Line Immunotherapy Combo Fails to Improve Survival in Lung Cancer Trial
Durvalumab plus tremelimumab did not meet the primary endpoint of the phase 3 MYSTIC trial evaluating improvement in overall survival and progression-free survival compared with chemotherapy.
Trending News Today: FDA Panel Recommends Co-prescribing Naloxone with Painkillers
Disparities Found in HIV Prevention Among Different Groups of Black Women
Foreign-born black women aren’t benefiting from HIV prevention programs at the same rates as other women.
Schizophrenia: Quality of Care & Relapse Prevention
Watch
Emerging Therapies & Strategies in Schizophrenia
Improving Resistance to Use LAI Therapy in Schizophrenia
LAI Antipsychotics in Schizophrenia: Clinician's Role
LAI Antipsychotics in Schizophrenia: Tolerability
LAI Antipsychotics: Treatment Selection in Schizophrenia
LAI Antipsychotics: Establishing a Treatment Plan
Underutilization of LAI Antipsychotics in Schizophrenia
Effects of Schizophrenia Relapse on Hospitalization
Preventing Relapses in Schizophrenia
Consequences of Relapses in Schizophrenia
Predictors of Relapse in Schizophrenia
Current Challenges in the Treatment of Schizophrenia
Optimal Treatment of Schizophrenia: Take-Home Messages
Overcoming Obstacles to LAIs in Schizophrenia Management
Schizophrenia: Switching to a Long-Acting Injectable
Benefit of Long Acting Injectables in Schizophrenia
Adherence to Oral Agents in Schizophrenia Management
Schizophrenia: Understanding the Impact of Adherence
Schizophrenia: Consequences of Multiple Relapses
Importance of Relapse Prevention in Schizophrenia
Unmet Needs and Challenges in Managing Schizophrenia
Partnership Designed to Improve Medication Adherence Among Patients with Type 2 Diabetes
The program launched by the Baltimore-based organizations is the first of its kind to leverage video technology and a public health practice known as Directly Observed Therapy, or DOT.
